Inhaled nitric oxide in term infants with hypoxemic respiratory failure-Reference-Cited by-同舟云学术

Inhaled nitric oxide in term infants with hypoxemic respiratory failure

Published:1996-08 Issue:2 Volume:129 Page:279-286
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Barefield Elaine S.,Karle Virginia A.,Philips Joseph B.,Carlo Waldemar A.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference14 articles.

1. Persistent pulmonary hypertension of the newborn: the black box revisited;Walsh-Sukys;Clin Perinatol,1993

2. Treatment of persistent pulmonary hypertension of the newborn without hyperventilation: an assessment of diffusion of innovation;Walsh-Sukys;Pediatrics,1994

3. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation;Clark;J Pediatr,1994

4. Neonatal hypoxia and pulmonary vasospasm: response to tolazoline;Goetzman;J Pediatr,1976

5. Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension;Soifer;J Pediatr,1988

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echocardiographic Assessment of Pulmonary Arterial Hypertension Following Inhaled Nitric Oxide in Infants with Severe Bronchopulmonary Dysplasia;Neonatology;2023

2. Nitric oxide: Clinical applications in critically ill patients;Nitric Oxide;2022-04

3. Congenital Diaphragmatic Hernia: Core Review and Novel Updates;Neonatal Network;2021-08-01

4. Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment;Comprehensive Physiology;2021-06-30

5. Repurposing of the PDE5 Inhibitor Sildenafil for the Treatment of Persistent Pulmonary Hypertension in Neonates;Current Medicinal Chemistry;2021-05-04